Bernards Rene - Insider Non-Derivative Transactions at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Oct 3, 2023, Bernards Rene's relationship to LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) is Director, and currently has 25,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LIXT insiders.

Data Source: SEC.
Bernards Rene - Insider Non-Derivative Transactions of LIXT Common Stock
Bernards Rene - Insider Non-Derivative Transactions at LIXT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Oct 4, 2023 P -- (Common Stock) 5527 2.51 0
Oct 4, 2023 P -- (Common Stock) 5527 2.51 25000
Oct 3, 2023 P -- (Common Stock) 4473 2.29 0
Oct 3, 2023 P -- (Common Stock) 4473 2.29 19473